Author

Gina Lange

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5086081495

Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma

2019 · Mattia Novo, M Hasib Sidiqi, et al. · Blood · 7

Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel

2021 · Megan Melody, Sangeetha Gandhi, et al. · European Journal Of Haematology · 6

QIM19-136: Developing an Ideal CAR-T Cell Therapy Patient Experience Through Human-Centered Design and Innovation

2019 · Allison Matthews, Surbhi Sidana, et al. · Journal of the National Comprehensive Cancer Network · 4

Association of lymphocyte to monocyte ratio with clinical response and survival in patients with relapsed, aggressive non-Hodgkin lymphoma treated with axicabtagene ciloleucel CAR-T.

2020 · Abdullah S. Al Saleh, Sangeetha Gandhi, et al. · Journal of Clinical Oncology · 1

Impact of type of salvage therapy (ST) and response to bridging therapy (BT) on CAR-T therapy outcomes for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (NHL).

2020 · Arushi Khurana, Abdullah S. Al Saleh, et al. · Journal of Clinical Oncology · 1

Baseline Hypoalbuminemia Does Not Appear to be an Adverse Prognostic Factor in Patients with Relapse/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)

2019 · Megan Melody, Sangeetha Gandhi, et al. · Blood · 1

Expanding Cellular Therapy Research Beyond Cancer through Multidisciplinary Infrastructure and Process Innovation

2026 · Jessica Haug, Ann Strege, et al. · Transplantation and Cellular Therapy

Early Integration of Cellular, Molecular, and Bispecific Therapy Education for Nurses

2026 · Katherine Houdek, Mr. Matthew Hathcock, et al. · Transplantation and Cellular Therapy

Decrease in Serum Albumin Level Predicts Onset of Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in Patients with Relapsed/Refractory B-Cell Lymphomas Treated with Axicabtagene Ciloleucel (axi-cel)

2020 · Zaid Abdel Rahman, Sangeetha Gandhi, et al. · Transplantation and Cellular Therapy

Works count: 9

Citation count: 20

H-index: 3

I10-index: